Showing 281 - 300 results of 442 for search '"opioid"', query time: 0.06s Refine Results
  1. 281

    Ketamine for the Treatment of Chronic Pain: A Comprehensive Review by Jacob E. Israel, Samantha St Pierre, Emily Ellis, Josephine S. Hanukaai, Nazir Noor, Giustino Varrassi, Markus Wells, Alan D. Kaye

    Published 2021-07-01
    “… # Conclusion First-line treatment for many chronic pain conditions includes NSAIDs, antidepressants, anticonvulsants, and opioids. However, these treatment methods are unsuccessful in a subset of patients. …”
    Get full text
    Article
  2. 282

    Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity by Gabriel Olmos, Jerònia Lladó

    Published 2014-01-01
    “…As microglial activation and upregulation of TNF-α expression is a common feature of several CNS diseases, as well as chronic opioid exposure and neuropathic pain, modulating TNF-α signaling may represent a valuable target for intervention.…”
    Get full text
    Article
  3. 283

    Artemisia dracunculus essential oil: phytochemical study, pre-treatment and co-treatment effects on morphine withdrawal syndrome by Zahra Lorigooini, Fatemeh Heibati, Seyyed Matin Ahmadi, Sareh Mohammadi, Mahmoud Rafieian-Kopaei

    Published 2025-01-01
    “…Medicinal herbs have been traditionally used in the management and treatment of opioid withdrawal syndrome and pain. The aim of this study was to determine the effect of A. dracunculus essential oil in reducing the symptoms of morphine withdrawal in mice. …”
    Get full text
    Article
  4. 284

    Supporting Mothers’ Engagement in a Community-Based Methadone Treatment Program by Nicole Letourneau, Mary Ann Campbell, Jennifer Woodland, Jennifer Colpitts

    Published 2013-01-01
    “…Unmanaged maternal opioid addiction poses health and social risks to both mothers and children in their care. …”
    Get full text
    Article
  5. 285

    Transversus Abdominis Plane Catheter Bolus Analgesia after Major Abdominal Surgery by Nils Bjerregaard, Lone Nikolajsen, Thomas Fichtner Bendtsen, Bodil Steen Rasmussen

    Published 2012-01-01
    “…Transversus abdominis plane (TAP) blocks have been shown to reduce pain and opioid requirements after abdominal surgery. The aim of the present case series was to demonstrate the use of TAP catheter injections of bupivacaine after major abdominal surgery. …”
    Get full text
    Article
  6. 286
  7. 287

    Evaluation of the functional gastrointestinal diseases concept from standpoints of Rome IV (2016) diagnostic criteria (review) by D. N. Andreyev, A. V. Zaborovsky, A. S. Trukhmanov, I. V. Mayev, V. T. Ivashkin

    Published 2018-08-01
    “…The new nosological entities with known causative factor (opioid-induced gastrointestinal hyperalgesia, opioidinduced constipation, cannabinoid induced hyperemesis syndrome), hypersensitive reflux syndrome, nausea and vomiting syndrome (that encompasses previously separate nosological forms: chronic idiopathic nausea and functional vomiting) were added to the new version of the classification. …”
    Get full text
    Article
  8. 288

    Lateral Quadratus Lumborum Block versus Transversus Abdominis Plane Block in Laparoscopic Surgery: A Randomized Controlled Study by Omar Sayed Fargaly, Maged Labib Boules, Mohamed Ahmed Hamed, Mohammed Abdel Aleem Abbas, Mohammed Ahmed Shawky

    Published 2022-01-01
    “…In comparison to the TAPB, the QL block delivers more successful pain relief, has an extended period of analgesic actions, extends interval to the 1st analgesic necessity, is accompanied with lesser morphine consumptions, and may be utilized in multimodal analgesia and opioid-sparing regimens after that laparoscopic operation. …”
    Get full text
    Article
  9. 289

    Comparison of two bolus doses of dexmedetomidine for prophylaxis against postoperative nausea and vomiting in highly susceptible patients: A randomized controlled trial by Maha Mohamed Ismail Youssef, Amr Raafat Mahmoud Seif, Kareem Nagy Abbass Ahmed, Ghada Abo Bakr, Gihan Mohamed Obayah, Mohamed Ramadan Ahmed Mohamed

    Published 2024-04-01
    “…Conclusion: A bolus dose of Dex having a concentration of 0.75 µ/kg decreased the incidence of PONV in high-risk patients, with subsequent reduction in postoperative opioid consumption and improvement of patients’ satisfaction.…”
    Get full text
    Article
  10. 290

    The Effect of Peritubal Infiltration with Bupivacaine and Morphine on Postoperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy by Isra Karaduman, Derya Karasu, Canan Yilmaz, Sedat Oner, Hilal Erdem Solak, Gulsen Korfali

    Published 2017-01-01
    “…We aimed to investigate the effect of peritubal local anesthetic and opioid infiltration on pain scores and analgesic consumption in patients who underwent percutaneous nephrolithotomy. …”
    Get full text
    Article
  11. 291

    Neuronal Plasticity Associated with Burn Injury and Its Relevance for Perception and Management of Pain in Burn Patients by Terence J Coderre, Manon Choinière

    Published 2000-01-01
    “…Recently acquired experimental evidence on postburn hyperalgesia, central hyperexcitability and changes in opioid sensitivity provides strong support that burn patients need an analgesic approach aimed at preventing or reducing the 'neural' memory of pain, including the use of more than one treatment modality. …”
    Get full text
    Article
  12. 292

    Effect of Low-Dose (Single-Dose) Magnesium Sulfate on Postoperative Analgesia in Hysterectomy Patients Receiving Balanced General Anesthesia by Arman Taheri, Katayoun Haryalchi, Mandana Mansour Ghanaie, Neda Habibi Arejan

    Published 2015-01-01
    “…Single dose of magnesium sulfate during balanced general anesthesia could be considered as effective and safe method to reduce postoperative pain and opioid consumption after TAH.…”
    Get full text
    Article
  13. 293

    Calcium-mediated mitochondrial fission and mitophagy drive glycolysis to facilitate arterivirus proliferation. by Zhe Sun, Zicheng Ma, Wandi Cao, Chenlong Jiang, Lei Guo, Kesen Liu, Yanni Gao, Juan Bai, Jiang Pi, Ping Jiang, Xing Liu

    Published 2025-01-01
    “…This process is associated with increased mitochondria-associated membranes (MAMs), mediated by the upregulated expression of sigma non-opioid intracellular receptor 1 (SIGMAR1). Elevated mitochondria Ca2+ further activates the Ca2+/CaM-dependent protein kinase kinase β (CaMKKβ)-AMP-activated protein kinase (AMPK)-dynamin-related protein 1 (DRP1) signaling pathway, which interacts with mitochondrial fission protein 1 (FIS1) and mitochondrial dynamics proteins of 49 kDa (MiD49) to promote mitochondrial fission. …”
    Get full text
    Article
  14. 294

    Treatment gap for mental and behavioral disorders in Punjab by Rohit Garg, Bir Singh Chavan, Subhash Das, Sonia Puri, Arvind A. Banavaram, Vivek Benegal, Girish N. Rao, Mathew Varghese, Gopalkrishna Gururaj

    Published 2023-12-01
    “…Results: The treatment gap for mental and behavioral disorders was 79.59%, and it was higher for common mental disorders than severe mental disorders and higher for alcohol and tobacco use disorders as compared to opioid use disorders. The median treatment lag was 6 months. …”
    Get full text
    Article
  15. 295

    Analgesic effect of intranasal ketamine in the treatment of chronic cancer pain by Secundino González Pardo, Lourdes González-Longoria Boada, Francisco López Muñoz

    Published 2022-05-01
    “…<strong>Background</strong>: cancer pain remains difficult to treat, especially when the patient is resistant to opioids. More and more alternatives are being sought to counteract and improve the symptoms caused by the disease. …”
    Get full text
    Article
  16. 296

    Substance Abuse and Rural Appalachian Pediatric Trauma in West Virginia by Joshua Rawson, Lindsey Thevenin, Isabella Balko, Federico Seifarth, Hal Meltzer, Vipul Dhumak, Amy Bush, Wesley Kimble, Sijin Wen, Pavithra Ellison

    Published 2022-01-01
    “…Benzodiazepine use increased from 0.8% to 1.8% (p<0.001), and opioid use increased from 1% to 4.9% (p<0.001). Conclusion. …”
    Get full text
    Article
  17. 297

    Effect Of Intraoperative Erector Spinae Block For Faster Recovery And Reduced Post-Operative Pain In Patients Undergoing Discectomies & Spinal Decompression by Arham Azizi, Athar Muniruddin Siddiqui, Naseem Munshi, Muhammad Salman Masroor, Zahra Salahuddin, Muhammad Hassan

    Published 2024-09-01
    “…It offers significant benefits over traditional pain management approaches, including reduced pain scores, lower opioid consumption, and shorter hospital stays. …”
    Get full text
    Article
  18. 298

    The Role of Thoracic Medial Branch Blocks in Managing Chronic Mid and Upper Back Pain: A Randomized, Double-Blind, Active-Control Trial with a 2-Year Followup by Laxmaiah Manchikanti, Vijay Singh, Frank J. E. Falco, Kimberly A. Cash, Vidyasagar Pampati, Bert Fellows

    Published 2012-01-01
    “…Outcome measures included the numeric rating scale (NRS), Oswestry Disability Index (ODI), opioid intake, and work status, at baseline, 3, 6, 12, 18, and 24 months. …”
    Get full text
    Article
  19. 299

    Pathogenesis of Functional Biliary Pain and Pharmacology of Trimebutin by E. L. Bueverova, O. Yu. Zolnikova, N. L. Dzhakhaya, A. V. Sedova, V. Т. Ivashkin

    Published 2024-03-01
    “…In the multilevel system of regulation of the gallbladder and sphincter apparatus, the opioid system occupies a special place. The agonist of peripheral receptors of the enkephalinergic system, trimebutine, in clinical studies led to the relief of biliary pain in more than 80 % of patients with functional biliary disorders, while a significant decrease in the severity of diarrhea, dyspeptic, and constipation syndromes was revealed.Conclusion. …”
    Get full text
    Article
  20. 300

    Possible erythropoietin pharmacotherapeutic targets on painful diabetic neuropathy in rats by SAMUEL SUAREZ-MENDEZ, DEYSI Y. BERMÚDEZ-OCAÑA

    Published 2025-02-01
    “….), methiothepin (non-selective 5-HT receptor antagonist; 0.01-0.1 mg/kg, i.p.) and naloxone (non-selective opioid receptor antagonist; 1 mg/kg). Intraperitoneal administration of erythropoietin (500-4000 UI/kg) prevented allodynia in diabetic rats. …”
    Get full text
    Article